These final results, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the principle of targeting ACKR3 as a novel way to modulate the opioid method, which could open up new therapeutic avenues for opioid-similar Problems. By ticking this box https://henrym257nke5.blogrelation.com/profile